Fig. 5From: Safety analysis of new medications in clinical trials: a simulation study to assess the differences between cause-specific and subdistribution frameworks in the presence of competing eventsMap of outcome categories of safety analysis with competing risks in the subdistribution setting. Legend: Figure 5 plots all outcome categories of safety analyses for all 400 conditions of interest by median time to first adverse event in verum and control groups. The colors represent the outcome categories described in Fig. 3Back to article page